Medical Patent News

RSS

AngioGenex files patent on first small molecule Id-inhibitors

AngioGenex Inc. has identified and filed a patent application on small molecules that are potent inhibitors of the Id proteins.

17 Oct 2007

Barr Labs and Par Pharmaceutical settle Diazepam patent case with Valeant

Barr Pharmaceuticals, Inc. today announced that its Barr Laboratories, Inc. subsidiary and Par Pharmaceutical Companies, Inc. have entered into a settlement agreement regarding their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's DIASTAT(R) diazepam rectal gel products.

15 Oct 2007

Alma Lasers responds to Lumenis patent claim

Alma Lasers Ltd. has filed a response denying all Lumenis' patent infringement claims. Alma Lasers will vigorously defend its position.

From Lumenis Inc. 15 Oct 2007

Aida granted new anti-cancer patent

One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.

12 Oct 2007

Brookhaven microgrid allows simultaneous study of multiple variables

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have developed a method for correlating the results of microscopic imaging techniques in a way that could lead to improved understanding, diagnosis, and possibly treatment of a variety of disease conditions, including Alzheimer's disease. The Laboratory has filed a U.S. provisional patent application for the invention.

10 Oct 2007

Mylan settles Levetiracetam patent case

Mylan Inc. has announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into an agreement to settle pending litigation with UCB Societe Anonyme and UCB Pharma Inc. (collectively, UCB) relating to Levetiracetam Tablets, 250mg, 500mg and 750mg, the generic version of UCB's Keppra.

4 Oct 2007

Biodel issued U.S. patent for VIAject and VIAtab

Biodel Inc. has announced the receipt of a notice of issuance from the United States Patent and Trademark Office (USPTO) for the Company's patent encompassing VIAject(TM) and VIAtab(TM), Biodel's two product candidates in clinical trials.

27 Sep 2007

Barr Pharmaceutical's Seasonale patent re-issued

Barr Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office (PTO) has reissued the Company's patent, U.S. Patent No. 5,898,032, for Seasonale extended-cycle oral contraceptive.

26 Sep 2007

New bioengineered antimicrobials help cystic fibrosis patients breathe easier

By better understanding how antimicrobials bind and thereby get inactivated in the mucus of air passages, researchers at the University of Illinois may have found a way to help cystic fibrosis patients fight off deadly infections.

25 Sep 2007

Barr confirms UROXATRAL patent challenge

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Sanofi- Aventis U.S. LLC in connection with its UROXATRAL (alfuzosin hydrochloride extended-release tablets), 10mg.

25 Sep 2007

BioNanomatrix issued new nanofluidics patent

The patent covers a novel technique for the integration of nanofluidic channels with sample delivery systems, enabling single molecules of DNA, RNA or other proteins to be separated out from standard laboratory samples for direct imaging and analysis.

25 Sep 2007

FAU receives patent for invention that induces and restores cardiac muscle function

Florida Atlantic University received U.S. patent no. 10/822,496, "Promoting Cardiac Cell Differentiation," based on an invention which induces and restores cardiac muscle function.

24 Sep 2007

New patented invention induces and restores cardiac muscle function

Florida Atlantic University received U.S. patent no. 10/822,496, "Promoting Cardiac Cell Differentiation," based on an invention which induces and restores cardiac muscle function.

21 Sep 2007

Helix BioPharma awarded U.S. patent for adjunct chemotherapy applications

Helix BioPharma Corp. has announced the issuance of its second DOS47 patent (U.S. Patent # 7,264,800) from the United States Patent & Trademark Office, describing a method and composition for combining targeted DOS47 therapeutics with weakly basic chemotherapeutic drugs in adjunct treatment applications.

18 Sep 2007

University patents and scientific discoveries

As universities continue transforming scientific discoveries into potentially lucrative patents, many wonder how this might be transforming academic science itself.

17 Sep 2007

Spectranetics to appeal decision in patent litigation

Spectranetics Corporation today announced it plans to appeal the verdict in a patent litigation dispute with Dr. Peter Rentrop in the U.S. District Court in the Southern District of New York.

13 Sep 2007

Angiotech receives favourable patent decision from New Zealand

Angiotech Pharmaceuticals, Inc. announced today that it received a favourable decision from the Intellectual Property Office of New Zealand regarding an attempt by Johnson & Johnson's subsidiary, Conor Medsystems Inc. ("Conor") to revoke Angiotech's New Zealand Patent 523799, which pertains to compositions comprising a polymer and paclitaxel, as well as, generally, to paclitaxel-eluting stents.

13 Sep 2007